Western Standard LLC’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.5M Buy
1,534,893
+1,399,979
+1,038% +$18.7M 11.4% 2
2025
Q1
$1.37M Buy
+134,914
New +$1.37M 0.81% 26